Will Celgene Raise Its 2020 Outlook?

Could Celgene (CELG) once again hike its long-term financial targets? J.P. Morgan analyst Cory Kasimov speculates that “that we think it’s possible — though far from certain” that the drug make could once again boost its target come January. Why? Kasimov had a recent dinner meeting with Celgene President and COO Mark Alles. Here’s his […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.